Cell-based therapy is an emerging field but one that has shown early promise for the
treatment of human kidney diseases. The most widely used cell is the mesenchymal stem …

Acute kidney injury (AKI) is a major clinical problem associated with high morbidity and
mortality. Likely due to its complex pathophysiology, therapies with a single pharmacological …

Objectives: Adult mesenchymal stem cells (MSC) have been proven to be of benefit to the
kidney in different experimental models of renal injuries. All studies have been performed in …

Kidney disease (KD) is a life-threatening disease characterized by high morbidity and
mortality in clinical settings, which can be caused by many reasons, and the incidence …

Acute kidney injury (AKI) is a common clinical entity with high morbidity and mortality rates
and ever increasing medical costs. A large number of patients who are hospitalized with …

Acute kidney injury (AKI) is a major health care condition with limited current treatment
options. Within this context, stem cells may provide a clinical approach for AKI. Moreover, a …

Mesenchymal stem cells are renoprotective in ischemia/reperfusion-induced acute renal
failure in rats. Background Adult stem cells are promising for the development of novel …

The recent findings indicate that under conditions of severe tubular injuries, transplantation
of mesenchymal stem cells (MSCs) may be a promising treatment in acute kidney diseases; …

The prevalence of kidney diseases is emerging as a public health problem. Stem cells
(SCs), currently considered as a promising tool for therapeutic application, have aroused …

Acute kidney injury (AKI) is a frequent clinical problem with a high mortality rate, generally
caused by ischemic insults. Nevertheless, the kidney has a remarkably high capacity to …